Home Pharmaceuticals Natural Killer (NK) Cell Therapeutics Market Size, Growth & Statistics - 2031

Natural Killer (NK) Cell Therapeutics Market Size & Outlook, 2023-2031

Natural Killer (NK) Cell Therapeutics Market Size, Share & Trends Analysis Report By Natural Killer (NK) cell Therapy Type (NK Cell Therapy (unmodified), CAR-NK Cell Therapy (modified), NK Cell Engager), By Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies), By Application (Cancer, Immunoproliferative Disorders, Acute Infectious Diseases, Gastrointestinal Diseases, Others), By Indication (Hepatocellular Carcinoma (HCC), Acute Myeloid Leukemia (AML), Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL), Peripheral T-Cell Lymphoma (PTCL).), By Pipeline Product (AFM13, MG4101, GTA002 (oNKordA), TAK-007) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRPH54334DR
Last Updated : May, 2023
Pages : 110
Author : Mitiksha Koul
Format : PDF, Excel

Market Segmentation

  1. Natural Killer (NK) Cell Therapeutics Market, By Natural Killer (NK) cell Therapy Type (2021-2031)
    1. NK Cell Therapy (unmodified)
    2. CAR-NK Cell Therapy (modified)
    3. NK Cell Engager
  2. Natural Killer (NK) Cell Therapeutics Market, By Approaches (2021-2031)
    1. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
    2. Bispecific Antibodies
  3. Natural Killer (NK) Cell Therapeutics Market, By Application (2021-2031)
    1. Cancer
    2. Immunoproliferative Disorders
    3. Acute Infectious Diseases
    4. Gastrointestinal Diseases
    5. Others
  4. Natural Killer (NK) Cell Therapeutics Market, By Indication (2021-2031)
    1. Hepatocellular Carcinoma (HCC)
    2. Acute Myeloid Leukemia (AML)
    3. Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL)
    4. Peripheral T-Cell Lymphoma (PTCL).
  5. Natural Killer (NK) Cell Therapeutics Market, By Pipeline Product (2021-2031)
    1. AFM13
    2. MG4101
    3. GTA002 (oNKordA)
    4. TAK-007
    1. North America
      1. North America Natural Killer (NK) Cell Therapeutics Market, By Natural Killer (NK) cell Therapy Type
        1. NK Cell Therapy (unmodified)
          1. CAR-NK Cell Therapy (modified)
            1. NK Cell Engager
            2. North America Natural Killer (NK) Cell Therapeutics Market, By Approaches
              1. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
                1. Bispecific Antibodies
                2. North America Natural Killer (NK) Cell Therapeutics Market, By Application
                  1. Cancer
                    1. Immunoproliferative Disorders
                      1. Acute Infectious Diseases
                        1. Gastrointestinal Diseases
                          1. Others
                          2. North America Natural Killer (NK) Cell Therapeutics Market, By Indication
                            1. Hepatocellular Carcinoma (HCC)
                              1. Acute Myeloid Leukemia (AML)
                                1. Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL)
                                  1. Peripheral T-Cell Lymphoma (PTCL).
                                  2. North America Natural Killer (NK) Cell Therapeutics Market, By Pipeline Product
                                    1. AFM13
                                      1. MG4101
                                        1. GTA002 (oNKordA)
                                          1. TAK-007
                                          2. U.S.
                                            1. U.S. Natural Killer (NK) Cell Therapeutics Market, By Natural Killer (NK) cell Therapy Type
                                              1. NK Cell Therapy (unmodified)
                                                1. CAR-NK Cell Therapy (modified)
                                                  1. NK Cell Engager
                                                  2. U.S. Natural Killer (NK) Cell Therapeutics Market, By Approaches
                                                    1. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
                                                      1. Bispecific Antibodies
                                                      2. U.S. Natural Killer (NK) Cell Therapeutics Market, By Application
                                                        1. Cancer
                                                          1. Immunoproliferative Disorders
                                                            1. Acute Infectious Diseases
                                                              1. Gastrointestinal Diseases
                                                                1. Others
                                                                2. U.S. Natural Killer (NK) Cell Therapeutics Market, By Indication
                                                                  1. Hepatocellular Carcinoma (HCC)
                                                                    1. Acute Myeloid Leukemia (AML)
                                                                      1. Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL)
                                                                        1. Peripheral T-Cell Lymphoma (PTCL).
                                                                        2. U.S. Natural Killer (NK) Cell Therapeutics Market, By Pipeline Product
                                                                          1. AFM13
                                                                            1. MG4101
                                                                              1. GTA002 (oNKordA)
                                                                                1. TAK-007
                                                                              2. Canada
                                                                            2. Europe
                                                                              1. Europe Natural Killer (NK) Cell Therapeutics Market, By Natural Killer (NK) cell Therapy Type
                                                                                1. NK Cell Therapy (unmodified)
                                                                                  1. CAR-NK Cell Therapy (modified)
                                                                                    1. NK Cell Engager
                                                                                    2. Europe Natural Killer (NK) Cell Therapeutics Market, By Approaches
                                                                                      1. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
                                                                                        1. Bispecific Antibodies
                                                                                        2. Europe Natural Killer (NK) Cell Therapeutics Market, By Application
                                                                                          1. Cancer
                                                                                            1. Immunoproliferative Disorders
                                                                                              1. Acute Infectious Diseases
                                                                                                1. Gastrointestinal Diseases
                                                                                                  1. Others
                                                                                                  2. Europe Natural Killer (NK) Cell Therapeutics Market, By Indication
                                                                                                    1. Hepatocellular Carcinoma (HCC)
                                                                                                      1. Acute Myeloid Leukemia (AML)
                                                                                                        1. Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL)
                                                                                                          1. Peripheral T-Cell Lymphoma (PTCL).
                                                                                                          2. Europe Natural Killer (NK) Cell Therapeutics Market, By Pipeline Product
                                                                                                            1. AFM13
                                                                                                              1. MG4101
                                                                                                                1. GTA002 (oNKordA)
                                                                                                                  1. TAK-007
                                                                                                                  2. U.K.
                                                                                                                    1. U.K. Natural Killer (NK) Cell Therapeutics Market, By Natural Killer (NK) cell Therapy Type
                                                                                                                      1. NK Cell Therapy (unmodified)
                                                                                                                        1. CAR-NK Cell Therapy (modified)
                                                                                                                          1. NK Cell Engager
                                                                                                                          2. U.K. Natural Killer (NK) Cell Therapeutics Market, By Approaches
                                                                                                                            1. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
                                                                                                                              1. Bispecific Antibodies
                                                                                                                              2. U.K. Natural Killer (NK) Cell Therapeutics Market, By Application
                                                                                                                                1. Cancer
                                                                                                                                  1. Immunoproliferative Disorders
                                                                                                                                    1. Acute Infectious Diseases
                                                                                                                                      1. Gastrointestinal Diseases
                                                                                                                                        1. Others
                                                                                                                                        2. U.K. Natural Killer (NK) Cell Therapeutics Market, By Indication
                                                                                                                                          1. Hepatocellular Carcinoma (HCC)
                                                                                                                                            1. Acute Myeloid Leukemia (AML)
                                                                                                                                              1. Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL)
                                                                                                                                                1. Peripheral T-Cell Lymphoma (PTCL).
                                                                                                                                                2. U.K. Natural Killer (NK) Cell Therapeutics Market, By Pipeline Product
                                                                                                                                                  1. AFM13
                                                                                                                                                    1. MG4101
                                                                                                                                                      1. GTA002 (oNKordA)
                                                                                                                                                        1. TAK-007
                                                                                                                                                      2. Germany
                                                                                                                                                      3. France
                                                                                                                                                      4. Spain
                                                                                                                                                      5. Italy
                                                                                                                                                      6. Russia
                                                                                                                                                      7. Nordic
                                                                                                                                                      8. Benelux
                                                                                                                                                      9. Rest of Europe
                                                                                                                                                    2. APAC
                                                                                                                                                      1. APAC Natural Killer (NK) Cell Therapeutics Market, By Natural Killer (NK) cell Therapy Type
                                                                                                                                                        1. NK Cell Therapy (unmodified)
                                                                                                                                                          1. CAR-NK Cell Therapy (modified)
                                                                                                                                                            1. NK Cell Engager
                                                                                                                                                            2. APAC Natural Killer (NK) Cell Therapeutics Market, By Approaches
                                                                                                                                                              1. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
                                                                                                                                                                1. Bispecific Antibodies
                                                                                                                                                                2. APAC Natural Killer (NK) Cell Therapeutics Market, By Application
                                                                                                                                                                  1. Cancer
                                                                                                                                                                    1. Immunoproliferative Disorders
                                                                                                                                                                      1. Acute Infectious Diseases
                                                                                                                                                                        1. Gastrointestinal Diseases
                                                                                                                                                                          1. Others
                                                                                                                                                                          2. APAC Natural Killer (NK) Cell Therapeutics Market, By Indication
                                                                                                                                                                            1. Hepatocellular Carcinoma (HCC)
                                                                                                                                                                              1. Acute Myeloid Leukemia (AML)
                                                                                                                                                                                1. Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL)
                                                                                                                                                                                  1. Peripheral T-Cell Lymphoma (PTCL).
                                                                                                                                                                                  2. APAC Natural Killer (NK) Cell Therapeutics Market, By Pipeline Product
                                                                                                                                                                                    1. AFM13
                                                                                                                                                                                      1. MG4101
                                                                                                                                                                                        1. GTA002 (oNKordA)
                                                                                                                                                                                          1. TAK-007
                                                                                                                                                                                          2. China
                                                                                                                                                                                            1. China Natural Killer (NK) Cell Therapeutics Market, By Natural Killer (NK) cell Therapy Type
                                                                                                                                                                                              1. NK Cell Therapy (unmodified)
                                                                                                                                                                                                1. CAR-NK Cell Therapy (modified)
                                                                                                                                                                                                  1. NK Cell Engager
                                                                                                                                                                                                  2. China Natural Killer (NK) Cell Therapeutics Market, By Approaches
                                                                                                                                                                                                    1. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
                                                                                                                                                                                                      1. Bispecific Antibodies
                                                                                                                                                                                                      2. China Natural Killer (NK) Cell Therapeutics Market, By Application
                                                                                                                                                                                                        1. Cancer
                                                                                                                                                                                                          1. Immunoproliferative Disorders
                                                                                                                                                                                                            1. Acute Infectious Diseases
                                                                                                                                                                                                              1. Gastrointestinal Diseases
                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                2. China Natural Killer (NK) Cell Therapeutics Market, By Indication
                                                                                                                                                                                                                  1. Hepatocellular Carcinoma (HCC)
                                                                                                                                                                                                                    1. Acute Myeloid Leukemia (AML)
                                                                                                                                                                                                                      1. Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL)
                                                                                                                                                                                                                        1. Peripheral T-Cell Lymphoma (PTCL).
                                                                                                                                                                                                                        2. China Natural Killer (NK) Cell Therapeutics Market, By Pipeline Product
                                                                                                                                                                                                                          1. AFM13
                                                                                                                                                                                                                            1. MG4101
                                                                                                                                                                                                                              1. GTA002 (oNKordA)
                                                                                                                                                                                                                                1. TAK-007
                                                                                                                                                                                                                              2. Korea
                                                                                                                                                                                                                              3. Japan
                                                                                                                                                                                                                              4. India
                                                                                                                                                                                                                              5. Australia
                                                                                                                                                                                                                              6. Taiwan
                                                                                                                                                                                                                              7. South East Asia
                                                                                                                                                                                                                              8. Rest of Asia-Pacific
                                                                                                                                                                                                                            2. Middle East and Africa
                                                                                                                                                                                                                              1. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market, By Natural Killer (NK) cell Therapy Type
                                                                                                                                                                                                                                1. NK Cell Therapy (unmodified)
                                                                                                                                                                                                                                  1. CAR-NK Cell Therapy (modified)
                                                                                                                                                                                                                                    1. NK Cell Engager
                                                                                                                                                                                                                                    2. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market, By Approaches
                                                                                                                                                                                                                                      1. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
                                                                                                                                                                                                                                        1. Bispecific Antibodies
                                                                                                                                                                                                                                        2. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market, By Application
                                                                                                                                                                                                                                          1. Cancer
                                                                                                                                                                                                                                            1. Immunoproliferative Disorders
                                                                                                                                                                                                                                              1. Acute Infectious Diseases
                                                                                                                                                                                                                                                1. Gastrointestinal Diseases
                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                  2. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market, By Indication
                                                                                                                                                                                                                                                    1. Hepatocellular Carcinoma (HCC)
                                                                                                                                                                                                                                                      1. Acute Myeloid Leukemia (AML)
                                                                                                                                                                                                                                                        1. Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL)
                                                                                                                                                                                                                                                          1. Peripheral T-Cell Lymphoma (PTCL).
                                                                                                                                                                                                                                                          2. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market, By Pipeline Product
                                                                                                                                                                                                                                                            1. AFM13
                                                                                                                                                                                                                                                              1. MG4101
                                                                                                                                                                                                                                                                1. GTA002 (oNKordA)
                                                                                                                                                                                                                                                                  1. TAK-007
                                                                                                                                                                                                                                                                  2. UAE
                                                                                                                                                                                                                                                                    1. UAE Natural Killer (NK) Cell Therapeutics Market, By Natural Killer (NK) cell Therapy Type
                                                                                                                                                                                                                                                                      1. NK Cell Therapy (unmodified)
                                                                                                                                                                                                                                                                        1. CAR-NK Cell Therapy (modified)
                                                                                                                                                                                                                                                                          1. NK Cell Engager
                                                                                                                                                                                                                                                                          2. UAE Natural Killer (NK) Cell Therapeutics Market, By Approaches
                                                                                                                                                                                                                                                                            1. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
                                                                                                                                                                                                                                                                              1. Bispecific Antibodies
                                                                                                                                                                                                                                                                              2. UAE Natural Killer (NK) Cell Therapeutics Market, By Application
                                                                                                                                                                                                                                                                                1. Cancer
                                                                                                                                                                                                                                                                                  1. Immunoproliferative Disorders
                                                                                                                                                                                                                                                                                    1. Acute Infectious Diseases
                                                                                                                                                                                                                                                                                      1. Gastrointestinal Diseases
                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                        2. UAE Natural Killer (NK) Cell Therapeutics Market, By Indication
                                                                                                                                                                                                                                                                                          1. Hepatocellular Carcinoma (HCC)
                                                                                                                                                                                                                                                                                            1. Acute Myeloid Leukemia (AML)
                                                                                                                                                                                                                                                                                              1. Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL)
                                                                                                                                                                                                                                                                                                1. Peripheral T-Cell Lymphoma (PTCL).
                                                                                                                                                                                                                                                                                                2. UAE Natural Killer (NK) Cell Therapeutics Market, By Pipeline Product
                                                                                                                                                                                                                                                                                                  1. AFM13
                                                                                                                                                                                                                                                                                                    1. MG4101
                                                                                                                                                                                                                                                                                                      1. GTA002 (oNKordA)
                                                                                                                                                                                                                                                                                                        1. TAK-007
                                                                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                                                                      1. LATAM Natural Killer (NK) Cell Therapeutics Market, By Natural Killer (NK) cell Therapy Type
                                                                                                                                                                                                                                                                                                        1. NK Cell Therapy (unmodified)
                                                                                                                                                                                                                                                                                                          1. CAR-NK Cell Therapy (modified)
                                                                                                                                                                                                                                                                                                            1. NK Cell Engager
                                                                                                                                                                                                                                                                                                            2. LATAM Natural Killer (NK) Cell Therapeutics Market, By Approaches
                                                                                                                                                                                                                                                                                                              1. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
                                                                                                                                                                                                                                                                                                                1. Bispecific Antibodies
                                                                                                                                                                                                                                                                                                                2. LATAM Natural Killer (NK) Cell Therapeutics Market, By Application
                                                                                                                                                                                                                                                                                                                  1. Cancer
                                                                                                                                                                                                                                                                                                                    1. Immunoproliferative Disorders
                                                                                                                                                                                                                                                                                                                      1. Acute Infectious Diseases
                                                                                                                                                                                                                                                                                                                        1. Gastrointestinal Diseases
                                                                                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                                                                                          2. LATAM Natural Killer (NK) Cell Therapeutics Market, By Indication
                                                                                                                                                                                                                                                                                                                            1. Hepatocellular Carcinoma (HCC)
                                                                                                                                                                                                                                                                                                                              1. Acute Myeloid Leukemia (AML)
                                                                                                                                                                                                                                                                                                                                1. Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL)
                                                                                                                                                                                                                                                                                                                                  1. Peripheral T-Cell Lymphoma (PTCL).
                                                                                                                                                                                                                                                                                                                                  2. LATAM Natural Killer (NK) Cell Therapeutics Market, By Pipeline Product
                                                                                                                                                                                                                                                                                                                                    1. AFM13
                                                                                                                                                                                                                                                                                                                                      1. MG4101
                                                                                                                                                                                                                                                                                                                                        1. GTA002 (oNKordA)
                                                                                                                                                                                                                                                                                                                                          1. TAK-007
                                                                                                                                                                                                                                                                                                                                          2. Brazil
                                                                                                                                                                                                                                                                                                                                            1. Brazil Natural Killer (NK) Cell Therapeutics Market, By Natural Killer (NK) cell Therapy Type
                                                                                                                                                                                                                                                                                                                                              1. NK Cell Therapy (unmodified)
                                                                                                                                                                                                                                                                                                                                                1. CAR-NK Cell Therapy (modified)
                                                                                                                                                                                                                                                                                                                                                  1. NK Cell Engager
                                                                                                                                                                                                                                                                                                                                                  2. Brazil Natural Killer (NK) Cell Therapeutics Market, By Approaches
                                                                                                                                                                                                                                                                                                                                                    1. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
                                                                                                                                                                                                                                                                                                                                                      1. Bispecific Antibodies
                                                                                                                                                                                                                                                                                                                                                      2. Brazil Natural Killer (NK) Cell Therapeutics Market, By Application
                                                                                                                                                                                                                                                                                                                                                        1. Cancer
                                                                                                                                                                                                                                                                                                                                                          1. Immunoproliferative Disorders
                                                                                                                                                                                                                                                                                                                                                            1. Acute Infectious Diseases
                                                                                                                                                                                                                                                                                                                                                              1. Gastrointestinal Diseases
                                                                                                                                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                                                                                                                                2. Brazil Natural Killer (NK) Cell Therapeutics Market, By Indication
                                                                                                                                                                                                                                                                                                                                                                  1. Hepatocellular Carcinoma (HCC)
                                                                                                                                                                                                                                                                                                                                                                    1. Acute Myeloid Leukemia (AML)
                                                                                                                                                                                                                                                                                                                                                                      1. Relapsed Or Refractory (r/r) B-Cell Non-Hodgkin's Lymphoma (NHL)
                                                                                                                                                                                                                                                                                                                                                                        1. Peripheral T-Cell Lymphoma (PTCL).
                                                                                                                                                                                                                                                                                                                                                                        2. Brazil Natural Killer (NK) Cell Therapeutics Market, By Pipeline Product
                                                                                                                                                                                                                                                                                                                                                                          1. AFM13
                                                                                                                                                                                                                                                                                                                                                                            1. MG4101
                                                                                                                                                                                                                                                                                                                                                                              1. GTA002 (oNKordA)
                                                                                                                                                                                                                                                                                                                                                                                1. TAK-007
                                                                                                                                                                                                                                                                                                                                                                              2. Mexico
                                                                                                                                                                                                                                                                                                                                                                              3. Argentina
                                                                                                                                                                                                                                                                                                                                                                              4. Chile
                                                                                                                                                                                                                                                                                                                                                                              5. Colombia
                                                                                                                                                                                                                                                                                                                                                                              6. Rest of LATAM

                                                                                                                                                                                                                                                                                                                                                                          Available for purchase with detailed segment data, forecasts, and regional insights.

                                                                                                                                                                                                                                                                                                                                                                          Get This Report

                                                                                                                                                                                                                                                                                                                                                                          Download Free Sample

                                                                                                                                                                                                                                                                                                                                                                          Note: Please ensure you provide an active email address as we will be sending sample details via email.
                                                                                                                                                                                                                                                                                                                                                                          The button will be active once the above form is filled

                                                                                                                                                                                                                                                                                                                                                                          Our Clients:

                                                                                                                                                                                                                                                                                                                                                                          LG Electronics
                                                                                                                                                                                                                                                                                                                                                                          AMCAD Engineering
                                                                                                                                                                                                                                                                                                                                                                          KOBE STEEL LTD.
                                                                                                                                                                                                                                                                                                                                                                          Hindustan National Glass & Industries Limited
                                                                                                                                                                                                                                                                                                                                                                          Voith Group
                                                                                                                                                                                                                                                                                                                                                                          International Paper
                                                                                                                                                                                                                                                                                                                                                                          Hansol Paper
                                                                                                                                                                                                                                                                                                                                                                          Whirlpool Corporation
                                                                                                                                                                                                                                                                                                                                                                          Sony
                                                                                                                                                                                                                                                                                                                                                                          Samsung Electronics
                                                                                                                                                                                                                                                                                                                                                                          Qualcomm
                                                                                                                                                                                                                                                                                                                                                                          Google
                                                                                                                                                                                                                                                                                                                                                                          Fiserv
                                                                                                                                                                                                                                                                                                                                                                          Veto-Pharma
                                                                                                                                                                                                                                                                                                                                                                          Nippon Becton Dickinson
                                                                                                                                                                                                                                                                                                                                                                          Merck
                                                                                                                                                                                                                                                                                                                                                                          Argon Medical Devices
                                                                                                                                                                                                                                                                                                                                                                          Abbott
                                                                                                                                                                                                                                                                                                                                                                          Ajinomoto
                                                                                                                                                                                                                                                                                                                                                                          Denon
                                                                                                                                                                                                                                                                                                                                                                          Doosan
                                                                                                                                                                                                                                                                                                                                                                          Meiji Seika Kaisha Ltd
                                                                                                                                                                                                                                                                                                                                                                          LG Chemicals
                                                                                                                                                                                                                                                                                                                                                                          LCY chemical group
                                                                                                                                                                                                                                                                                                                                                                          Bayer
                                                                                                                                                                                                                                                                                                                                                                          Airrane
                                                                                                                                                                                                                                                                                                                                                                          BASF
                                                                                                                                                                                                                                                                                                                                                                          Toyota Industries
                                                                                                                                                                                                                                                                                                                                                                          Nissan Motors
                                                                                                                                                                                                                                                                                                                                                                          Neenah
                                                                                                                                                                                                                                                                                                                                                                          Mitsubishi
                                                                                                                                                                                                                                                                                                                                                                          Hyundai Motor Company

                                                                                                                                                                                                                                                                                                                                                                          We are featured on :

                                                                                                                                                                                                                                                                                                                                                                          Address:
                                                                                                                                                                                                                                                                                                                                                                          Office 515 A, Amanora Chambers,
                                                                                                                                                                                                                                                                                                                                                                          Amanora Park Town, Hadapsar,
                                                                                                                                                                                                                                                                                                                                                                          Pune 411028, Maharashtra, India.
                                                                                                                                                                                                                                                                                                                                                                          Contact Us:
                                                                                                                                                                                                                                                                                                                                                                          +1 646 905 0080 (U.S.)
                                                                                                                                                                                                                                                                                                                                                                          +91 8087085354 (India)
                                                                                                                                                                                                                                                                                                                                                                          +44 203 695 0070 (U.K.)

                                                                                                                                                                                                                                                                                                                                                                          sales@straitsresearch.com

                                                                                                                                                                                                                                                                                                                                                                          Quick Links
                                                                                                                                                                                                                                                                                                                                                                          Help
                                                                                                                                                                                                                                                                                                                                                                          Verified. Protected. Secure.
                                                                                                                                                                                                                                                                                                                                                                          DMCA.com Protection Status
                                                                                                                                                                                                                                                                                                                                                                          Secure Payments:
                                                                                                                                                                                                                                                                                                                                                                          Follow Us:
                                                                                                                                                                                                                                                                                                                                                                          www.straitsresearch.com © Copyright . All rights Reserved.